// App-Quantinova.ai

Tu1752 : PREDICTING RESPONSE TO MESALAMINE INDUCTION THERAPY IN CHILDREN NEWLY DIAGNOSED WITH MILD-TO-MODERATE ULCERATIVE COLITIS: THE PROTECT STUDY

Researchers

Presenter

  • Sonia Davis

Principal Investigators

  • Robert N. Baldassano

  • Ashish S. Patel

  • Marian D. Pfefferkorn

  • Anthony Otley

  • Melvin B. Heyman

  • Joshua D. Noe

  • Maria Oliva-Hemker

  • Paul A. Rufo

  • Marla Dubinsky

  • Nathan Gotman

  • Brendan M. Boyle

  • Alison Marquis

  • Subra Kugathasan

  • Thomas D. Walters

  • Jeffrey S. Hyams

  • Anne M. Griffiths

  • Neal S. Leleiko

  • Cary G. Sauer

  • David J. Keljo

  • James Markowitz

  • Susan S. Baker

  • Joel R. Rosh

Medical Centers

  • Connecticut Childrens Medical Center, Hartford, Connecticut, United States

  • John Hopkins University, Baltimore, Maryland, United States

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • Cohens Childrens Medical Center of NY, New Hyde Park, New York, United States

  • University of California, San Francisco, San Francisco, California, United States

  • Hasbro Childrens Hospital, Providence, Rhode Island, United States

  • Riley Childrens Hospital, Indianapolis, Indiana, United States

  • Cincinnati Childrens Hospital Medical Center, Wyoming, Ohio, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin , United States

  • Childrens Hospital Boston, Boston, Massachusetts, United States

  • Emory University, Atlanta, Georgia, United States

  • University of Buffalo, Buffalo, New York, United States

  • Hospital for Sick Children, Toronto, ON, Canada

  • UT Southwestern Medical Center, Dallas, Texas, United States

  • Nationwide Childrens Hospital/Dept. of Anes., Columbus, Ohio, United States

  • Pittsburgh Children's Hospital, Pittsburgh, Pennsylvania, United States

  • The Childrenaaas Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

  • University of North Carolina, Chapel Hill, North Carolina, United States

  • Montefiore Medical Center, Medicine, New York, United States

  • Goryeb Childrens Hospital/Atlantic Health, Morristown, New Jersey, United States

  • Children's - East Ontario, Ottawa, Ontario, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Human albumin

  • Body mass index

Drug/Treatment

  • Mesalamine

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim